-
08.01.2024
Fapon Delivers Customized IVD Solutions for the US Market at ADLM 2024
Fapon, a global leading life sciences company, is showcasing its innovative IVD total solutions at ADLM 2024, from July 28 to August 1 in Chicago. -
06.20.2024
A new breakthrough in AI-powered drug design — Fapon Digiwiser launches DeepConformer, an AI model for predicting the dynamic conformations of proteins
As an industry leader in protein dynamic conformations -
06.06.2024
Fapon Biopharma announces safer immunotherapy for cancers
The announcement is a testimony to Fapon Biopharma’s strength in developing anticancer drugs -
03.20.2024
Fapon and Stanford Healthcare Innovation Lab co-host virtual conference on RNA delivery and gene editing featuring nobel prize winner
The conference between Stanford Healthcare Innovation Lab and Fapon took place successfully -
02.08.2024
Fapon at Medlab Middle East 2024: advancing local healthcare through IVD technologies
Fapon aims to support the growth of the local IVD industry and enhance local healthcare services -
02.01.2024
Fapon and Bio Farma sign MOU for medical innovations
The memorandum will further solidify Fapon's global ecosystem for diagnostics and medical treatment -
12.15.2023
Fapon shines at JITMM 2023
Fapon showcased its expertise at the Joint International Tropical Medicine Meeting 2023 -
11.22.2023
Medica 2023: Fapon accelerates the development of its diagnostic ecosystem
At MEDICA, Fapon presented the latest advancements in its open platform-based diagnostic ecosystem -
11.09.2023
Fapon inaugurates state-of-the-art R&D center in Lexington, MA
Fapon is thrilled to announce the grand opening of its US-based R&D Center -
10.18.2023
Fapon shares its visionary strategies at the Inaugural Innovative Diagnostics and Therapeutics Forum
Fapon announced its strategic plans in innovative diagnostics and therapeutics business -
10.16.2023
Fapon Biotech joins Stanford University Healthcare Innovation Lab Affiliates Program
Fapon Biotech became an industry member of the Stanford University HIL Affiliates Program -
07.25.2023
Fapon launches the most efficient chemiluminescence immunoassay analyzer to date with throughput of 900 t/h
Fapon announced the launch of chemiluminescence immunoassay system Shine i8000/9000 -
01.26.2023
Fapon, LASCCO, abionic formed strategic collaboration for PSP sepsis diagnosis in China
Fapon entered into a strategic cooperation agreement with LASCCO SA and Abionic SA -
11.05.2022
Fapon Biotech in strategic partnership with Roche Diagnostics
Fapon Biotech officially went into strategic partnership with Roche Diagnostics China
